Published in Proc Natl Acad Sci U S A on November 01, 1992
A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med (1997) 3.57
Mechanisms for T cell receptor triggering. Nat Rev Immunol (2010) 2.30
T cell Ig and mucin 1 (TIM-1) is expressed on in vivo-activated T cells and provides a costimulatory signal for T cell activation. Proc Natl Acad Sci U S A (2005) 2.00
Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes. J Exp Med (1996) 1.98
Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem J (2003) 1.84
The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase. Mol Cell Biol (1994) 1.67
Evidence for a preformed transducer complex organized by the B cell antigen receptor. Proc Natl Acad Sci U S A (1996) 1.60
Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J Exp Med (1996) 1.50
In vitro activation of a transcription factor by gamma interferon requires a membrane-associated tyrosine kinase and is mimicked by vanadate. Mol Cell Biol (1993) 1.44
Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J Exp Med (1997) 1.37
Receptor-stimulated oxidation of SHP-2 promotes T-cell adhesion through SLP-76-ADAP. EMBO J (2005) 1.36
Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells. Proc Natl Acad Sci U S A (1995) 1.31
ZAP-70 association with T cell receptor zeta (TCRzeta): fluorescence imaging of dynamic changes upon cellular stimulation. J Cell Biol (1998) 1.29
Tyrosine phosphorylation of CD45 phosphotyrosine phosphatase by p50csk kinase creates a binding site for p56lck tyrosine kinase and activates the phosphatase. Mol Cell Biol (1994) 1.26
Activation of the Lck tyrosine protein kinase by hydrogen peroxide requires the phosphorylation of Tyr-394. Proc Natl Acad Sci U S A (1995) 1.26
T cell Ig and mucin domain-1-mediated T cell activation requires recruitment and activation of phosphoinositide 3-kinase. J Immunol (2008) 1.21
Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4. Proc Natl Acad Sci U S A (1999) 1.12
The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site. Mol Cell Biol (1993) 1.03
The tyrosine phosphatase PTPN22 discriminates weak self peptides from strong agonist TCR signals. Nat Immunol (2014) 1.02
Induction of tyrosine phosphorylation and T-cell activation by vanadate peroxide, an inhibitor of protein tyrosine phosphatases. Biochem J (1994) 0.97
Removal of C-terminal SRC kinase from the immune synapse by a new binding protein. Mol Cell Biol (2005) 0.97
Activation and tyrosine phosphorylation of p72syk as well as calcium mobilization after hydrogen peroxide stimulation in peripheral blood lymphocytes. Biochem J (1995) 0.96
Hematopoietic protein tyrosine phosphatase mediates beta2-adrenergic receptor-induced regulation of p38 mitogen-activated protein kinase in B lymphocytes. Mol Cell Biol (2008) 0.92
The large ectodomains of CD45 and CD148 regulate their segregation from and inhibition of ligated T-cell receptor. Blood (2013) 0.92
Phosphorylation of erythropoietin receptors in the endoplasmic reticulum by pervanadate-mediated inhibition of tyrosine phosphatases. Biochem J (1997) 0.92
Lipid raft-mediated Akt signaling as a therapeutic target in mantle cell lymphoma. Blood Cancer J (2013) 0.91
Phosphotyrosine phosphatase associated with band 3 protein in the human erythrocyte membrane. Biochem J (1996) 0.90
Thermal proteome profiling monitors ligand interactions with cellular membrane proteins. Nat Methods (2015) 0.89
Down-regulation of protein-tyrosine phosphatases activates an immune receptor in the absence of its translocation into lipid rafts. J Biol Chem (2010) 0.86
Involvement of phosphatases in proliferation, maturation, and hemoglobinization of developing erythroid cells. J Signal Transduct (2011) 0.78
Stimulatory effect of pervanadate on calcium signals and histamine secretion of RBL-2H3 cells. Biochem J (1994) 0.77
Regulation of vascular and gastric smooth muscle contractility by pervanadate. Br J Pharmacol (1994) 0.77
Protein Tyrosine Phosphatase Inhibition Prevents Experimental Cerebral Malaria by Precluding CXCR3 Expression on T Cells. Sci Rep (2017) 0.75
A cell culture model for T lymphocyte clonal anergy. Science (1990) 9.86
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med (1991) 8.78
Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science (1989) 7.78
Role of the CD28 receptor in T-cell activation. Immunol Today (1990) 4.89
T cell antigen receptor activation pathways: the tyrosine kinase connection. Cell (1991) 3.95
B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci U S A (1991) 3.84
Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. Proc Natl Acad Sci U S A (1990) 3.69
Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu Rev Immunol (1990) 3.55
Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation. J Immunol (1990) 3.51
CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol (1991) 3.47
T cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation. Science (1990) 3.23
Functional activation of the T-cell antigen receptor induces tyrosine phosphorylation of phospholipase C-gamma 1. Proc Natl Acad Sci U S A (1991) 2.88
Lymphokine-activated killer cells. Analysis of progenitors and effectors. J Exp Med (1986) 2.70
Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell (1989) 2.62
Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature (1990) 2.51
T cell activation induces rapid tyrosine phosphorylation of a limited number of cellular substrates. J Biol Chem (1989) 2.50
Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc Natl Acad Sci U S A (1991) 2.45
CD3 stimulation causes phosphorylation of phospholipase C-gamma 1 on serine and tyrosine residues in a human T-cell line. Proc Natl Acad Sci U S A (1991) 2.37
Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins. Cell (1985) 2.33
Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Nature (1991) 2.15
The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem (1990) 2.03
Tyrosine phosphorylation coupled to IgE receptor-mediated signal transduction and histamine release. Proc Natl Acad Sci U S A (1990) 1.98
src-related tyrosine protein kinases as signaling components in hematopoietic cells. Cancer Cells (1990) 1.92
Multichain immune recognition receptors: similarities in structure and signaling pathways. Immunol Today (1992) 1.90
Tyrosine phosphorylation in T cells is regulated by phosphatase activity: studies with phenylarsine oxide. Proc Natl Acad Sci U S A (1990) 1.80
Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum. Cell (1991) 1.79
Tyrosine phosphorylation provides an early and requisite signal for the activation of natural killer cell cytotoxic function. Proc Natl Acad Sci U S A (1991) 1.53
Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1. Cancer Res (1989) 1.51
Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. J Immunol (1991) 1.43
Phosphotyrosyl-protein phosphatase of TCRC-2 cells. J Biol Chem (1982) 1.41
Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the zeta chain. Proc Natl Acad Sci U S A (1991) 1.39
Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry (1989) 1.38
Thy-1- and Ly-6-mediated lymphokine production and growth inhibition of a T cell hybridoma require co-expression of the T cell antigen receptor complex. J Immunol (1988) 1.31
Two complementation classes of T200 (Ly-5) glycoprotein-negative mutants. Immunogenetics (1981) 1.18
A role for protein tyrosine kinase activity in natural cytotoxicity as well as antibody-dependent cellular cytotoxicity. Effects of herbimycin A. J Immunol (1992) 1.17
Vanadate stimulates oxygen consumption and tyrosine phosphorylation in electropermeabilized human neutrophils. J Biol Chem (1990) 1.12
Tyrosine kinase-regulated and inositol phosphate-independent Ca2+ elevation and mobilization in T cells. J Biol Chem (1992) 1.03
H2O2 potentiates phosphorylation of novel putative substrates for the insulin receptor kinase in intact Fao cells. J Biol Chem (1989) 0.96
Fc gamma receptor signal transduction in natural killer cells. Coupling to phospholipase C via a G protein-independent, but tyrosine kinase-dependent pathway. J Immunol (1991) 0.95
Expression of v-src in a murine T-cell hybridoma results in constitutive T-cell receptor phosphorylation and interleukin 2 production. Proc Natl Acad Sci U S A (1991) 0.94
Expression of the human epidermal growth factor receptor in a murine T-cell hybridoma. A transmembrane protein tyrosine kinase can synergize with the T-cell antigen receptor. J Biol Chem (1992) 0.83
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Identifying predictors of high quality care in English general practice: observational study. BMJ (2001) 9.34
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (1992) 5.94
Meta-MEME: motif-based hidden Markov models of protein families. Comput Appl Biosci (1997) 4.48
NKT cells: facts, functions and fallacies. Immunol Today (2000) 4.40
The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res (1986) 4.16
Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science (1994) 3.46
Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature (1994) 3.31
Measuring safety climate in health care. Qual Saf Health Care (2006) 2.90
Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A (2000) 2.80
Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase. Mol Cell Biol (1999) 2.77
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med (2001) 2.74
The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proc Natl Acad Sci U S A (2001) 2.65
Geriatric care in general practice. A medicosocial survey of 391 patients undertaken by health visitors. J R Coll Gen Pract (1969) 2.65
Extracellular adenosine triphosphate and adenosine in cancer. Oncogene (2010) 2.53
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma. Leukemia (2009) 2.50
Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood (2001) 2.45
Epidemiology of incident spinal fracture in a complete population. Spine (Phila Pa 1976) (1996) 2.12
Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma. Proc Natl Acad Sci U S A (2007) 2.10
NKT cells are phenotypically and functionally diverse. Eur J Immunol (1999) 1.97
Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis. J Biol Chem (1997) 1.88
Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc Natl Acad Sci U S A (1994) 1.84
Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J Exp Med (1995) 1.78
Role of ceramide in cellular senescence. J Biol Chem (1995) 1.74
Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells. Br J Pharmacol (2010) 1.65
Mutation of Tec family kinases alters T helper cell differentiation. Nat Immunol (2001) 1.63
P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood (1999) 1.61
Multiple physiological functions for multidrug transporter P-glycoprotein? Trends Biochem Sci (2000) 1.58
NKT cells and tumor immunity--a double-edged sword. Nat Immunol (2000) 1.53
Identification of RANTES receptors on human monocytic cells: competition for binding and desensitization by homologous chemotactic cytokines. J Exp Med (1993) 1.53
Array-based ELISAs for high-throughput analysis of human cytokines. Biotechniques (2001) 1.48
Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers. J Exp Med (1999) 1.45
CD1-restricted T cells and tumor immunity. Curr Top Microbiol Immunol (2007) 1.45
Targeting death-inducing receptors in cancer therapy. Oncogene (2007) 1.42
Tec family kinases modulate thresholds for thymocyte development and selection. J Exp Med (2000) 1.41
Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int Immunol (2001) 1.40
ParaMEME: a parallel implementation and a web interface for a DNA and protein motif discovery tool. Comput Appl Biosci (1996) 1.39
The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant (2008) 1.39
Geriatric care in a welfare home. Ulster Med J (1972) 1.36
Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perforin are caspase-dependent, but cell death is caspase-independent. J Biol Chem (1998) 1.36
Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood (2000) 1.31
Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction. J Immunol (1991) 1.31
The ever-expanding Ly49 gene family: repertoire and signaling. Immunol Rev (2001) 1.26
Constitutive expression of pore-forming protein in peripheral blood gamma/delta T cells: implication for their cytotoxic role in vivo. J Exp Med (1990) 1.24
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth. Cell Immunol (2001) 1.19
A role for protein tyrosine kinase activity in natural cytotoxicity as well as antibody-dependent cellular cytotoxicity. Effects of herbimycin A. J Immunol (1992) 1.17
Localization of granzyme B in the nucleus. A putative role in the mechanism of cytotoxic lymphocyte-mediated apoptosis. J Biol Chem (1996) 1.17
An anatomy of general practice. J R Coll Gen Pract (1969) 1.15
Immunopurification of functional Asp-ase (natural killer cell granzyme B) using a monoclonal antibody. Biochem Biophys Res Commun (1993) 1.14
Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. J Exp Med (1995) 1.14
Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils. Eur J Immunol (1995) 1.12
Molecular mechanisms of natural killer cell activation in response to cellular stress. Cell Death Differ (2013) 1.11
p53-dependent ceramide response to genotoxic stress. J Clin Invest (1998) 1.11
Maintenance of traditional cultural orientation is associated with lower rates of obesity and sedentary behaviours among African migrant children to Australia. Int J Obes (Lond) (2008) 1.09
A survey of sexual knowledge and attitudes in Borehamwood. Practitioner (1971) 1.08
Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H. J Leukoc Biol (1999) 1.08
Exploration of the Common Bile Duct for Stone. Drainage with T-Tube and Cholangiography. Br Med J (1941) 1.07
Redirecting mouse CTL against colon carcinoma: superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma. J Immunol (2001) 1.07
CTL granules: evolution of vesicles essential for combating virus infections. Immunol Today (1999) 1.07
Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. J Immunol (1998) 1.06
Evolution in action. Nature (1974) 1.06
Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures. Cancer Immunol Immunother (1986) 1.06
The effectiveness of nutrition interventions on dietary outcomes by relative social disadvantage: a systematic review. J Epidemiol Community Health (2008) 1.06
Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes. Diabetologia (2005) 1.06
NK cells and apoptosis. Immunol Cell Biol (1999) 1.04
Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr Opin Immunol (2000) 1.02
The public's response to the obesity epidemic in Australia: weight concerns and weight control practices of men and women. Public Health Nutr (2000) 1.01
Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2. Blood (1995) 1.01
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen. Gene Ther (2010) 1.00
HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance. Blood (2000) 1.00
A role for P-glycoprotein in regulating cell death. Leuk Lymphoma (2000) 0.99
Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy. Cancer Res (1999) 0.99
Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumor. Neurosurgery (1988) 0.99
P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation. Cell Death Differ (2002) 0.97
Functional association of FcepsilonRIgamma with arginine(632) of paired immunoglobulin-like receptor (PIR)-A3 in murine macrophages. Blood (1999) 0.97
Concerning the accuracy of MAST E-values. Bioinformatics (2000) 0.96
Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux. Cell Death Differ (2004) 0.96
Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines. Cell Death Differ (2013) 0.95
Granule serine proteases are normal nuclear constituents of natural killer cells. J Biol Chem (1994) 0.95
Adrenal hemangioblastoma in Von Hippel-Lindau disease as a cause of secondary erythrocytosis. Am J Med Sci (1987) 0.95
Expression of v-src in a murine T-cell hybridoma results in constitutive T-cell receptor phosphorylation and interleukin 2 production. Proc Natl Acad Sci U S A (1991) 0.94
Induction of T cell differentiation and lymphomagenesis in the thymus of mice with severe combined immune deficiency (SCID). J Immunol (1994) 0.94
Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL. J Immunol (2000) 0.94
Applicability of telemedicine for assessing patients with schizophrenia: acceptance and reliability. J Clin Psychiatry (1997) 0.94
Multiple congenital anomalies in a calf. J Vet Diagn Invest (1999) 0.94
Automated single-cell manipulation and sorting by light trapping. Appl Opt (1987) 0.93
Regulation of JAK3 expression and activation in human B cells and B cell malignancies. J Immunol (1995) 0.93
Bcl-2 acts upstream of the PARP protease and prevents its activation. Cell Death Differ (1997) 0.92
Immunoregulation in cancer-bearing hosts. Down-regulation of gene expression and cytotoxic function in CD8+ T cells. J Immunol (1992) 0.92
Perforin-dependent nuclear entry of granzyme B precedes apoptosis, and is not a consequence of nuclear membrane dysfunction. Cell Death Differ (1998) 0.92
Development and initial validation of a brief mental health outcome measure. J Pers Assess (1999) 0.92
The restricted expression of granzyme M in human lymphocytes. J Immunol (2001) 0.91
Infectious hepatitis in Leicester 1963-6. Br Med J (1967) 0.91
Emergency nurses' perceptions of critical incidents and stress debriefing. J Emerg Nurs (1993) 0.91
Dependence of granzyme B-mediated cell death on a pathway regulated by Bcl-2 or its viral homolog, BHRF1. Cell Death Differ (2000) 0.90
The subunit structure of the aliphatic amidase from Pseudomonas aeruginosa. Eur J Biochem (1973) 0.90
Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase. J Immunol (1997) 0.89
Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype. Gene Ther (2010) 0.89
Paired inhibitory and activating receptor signals. Rev Immunogenet (2000) 0.88
A programme of care for the elderly. Ulster Med J (1975) 0.88